Progestins: Pro-senescence therapy for ovarian cancer?

Modugno, 2012, Hormone response in ovarian cancer: time to reconsider as a clinical target?, Endocr Relat Cancer, 19, R255, 10.1530/ERC-12-0175

Diep, 2013, Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells, Cell Cycle, 12, 1433, 10.4161/cc.24550

Zheng, 2007, Hormonal therapy in ovarian cancer, Int J Gynecol Cancer, 17, 325, 10.1111/j.1525-1438.2006.00749.x

Langdon, 1998, Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen, Clin Cancer Res, 4, 2245

Kuilman, 2009, Senescence-messaging secretome: SMS-ing cellular stress, Nat Rev Cancer, 9, 81, 10.1038/nrc2560

Hannani, 2011, Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy, Cancer J, 17, 351, 10.1097/PPO.0b013e3182325d4d